Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 4 for:    11-C-0100
Previous Study | Return to List | Next Study

Gemcitabine and CT-011 for Resected Pancreatic Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2014 by Georgia Regents University
Sponsor:
Information provided by (Responsible Party):
Samir N. Khleif, Georgia Regents University
ClinicalTrials.gov Identifier:
NCT01313416
First received: March 10, 2011
Last updated: August 12, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2018
  Estimated Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)